Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jade Biosciences announced the grant of a non-qualified stock option award for 500,000 shares to Dr. Edward R. Conner, newly appointed Chief Medical Officer. The award was made under the company's Inducement Plan, complying with Nasdaq Listing Rule 5635(c)(4), with options priced at the closing market value of $25.38 per share and vesting over four…